SARS‐CoV‐2 Seroprevalence Trends in the Netherlands in the Variant of Concern Era: Input for Future Response

Documenti analoghi

• Seroprevalence of SARS‐CoV‐2 in 10 Regional Capitals of Cameroon, October–December 2020
  di: Karampreet Sachathep, et al.
  Pubblicazione: (2024)
• Unveiling the Spectrum of Respiratory Syncytial Virus Disease in Adults: From Community to Hospital
  di: Koos Korsten, et al.
  Pubblicazione: (2025)
• How Has the Disappearance of Influenza B/Yamagata Altered the Proportion of Influenza A and B Cases? Early Findings From Post‐COVID Pandemic Global Surveillance Data
  di: Marco Del Riccio, et al.
  Pubblicazione: (2025)
• Disease Burden of RSV Infections and Bronchiolitis in Young Children (< 5 Years) in Primary Care and Emergency Departments: A Systematic Literature Review
  di: Susanne Heemskerk, et al.
  Pubblicazione: (2024)
• Seroprevalence Trends of Antibodies to SARS‐CoV‐2 in South Korea, 2021–2022: A Repeated Cross‐Sectional Study
  di: Ah‐Ra Kim, et al.
  Pubblicazione: (2025)